RE: RENX AI15 Sep 2025 11:06
A.I in medicine not only in its core offerings ( eg below from August RNS) but also I its patented Virtual Tumour platform and its dosing app
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce the award of a second contract by a UK-based biotech client at the forefront of AI-driven drug development.